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Abstract
Background: Coronary angiography with two catheters is the traditional strategy for diagnostic coronary procedures. 
TIG I catheter permits to cannulate both coronary arteries, avoiding exchanging catheters during coronary angiography 
by transradial access.
Objective: The aim of this study is to evaluate the impact of one-catheter strategy, by avoiding catheter exchange, on 
coronary catheterization performance and economic costs.
Methods: Transradial coronary diagnostic procedures conducted from January 2013 to June 2017 were collected. One-catheter 
strategy (TIG I catheter) and two-catheter strategy (left and right Judkins catheters) were compared. The volume of iodinated 
contrast administered was the primary endpoint. Secondary endpoints included radial spasm, procedural duration (fluoroscopy 
time) and exposure to ionizing radiation (dose-area product and air kerma). Direct economic costs were also evaluated. 
For statistical analyses, two-tailed p-values < 0.05 were considered statistically significant.
Results: From a total of 1,953 procedures in 1,829 patients, 252 procedures were assigned to one-catheter strategy and 
1,701 procedures to two-catheter strategy. There were no differences in baseline characteristics between the groups. One-catheter 
strategy required less iodinated contrast [primary endpoint; (60–105)-mL vs. 92 (64–120)-mL; p < 0.001] than the two-catheter 
strategy. Also, the one-catheter group presented less radial spasm (5.2% vs. 9.3%, p = 0.022) and shorter fluoroscopy time 
[3.9 (2.2–8.0)-min vs. 4.8 (2.9–8.3)-min, p = 0.001] and saved costs [149 (140–160)-€/procedure vs. 171 (160–183)-€/procedure; 
p < 0.001]. No differences in dose-area product and air kerma were detected between the groups.
Conclusions: One-catheter strategy, with TIG I catheter, improves coronary catheterization performance and reduces 
economic costs compared to traditional two-catheter strategy in patients referred for coronary angiography. (Arq Bras 
Cardiol. 2019; 113(5):960-968)
Keywords: Cineagiography/methods; Cardiac Catheterization/economic; Radiation, Ionizing;; Fluoroscopy; Cost 
Savings/economic.
Introduction
Coronary angiography is the “gold standard” technique 
for the evaluation of coronary arteries.1 Due to its invasive 
nature, coronary angiography is associated with multiple 
complications. However, the rate of complications of 
coronary angiography procedures has decreased over time.1 
Transradial access plays a key role by reducing vascular 
complications and mortality in patients undergoing invasive 
coronary procedures.1-3
Transradial access is currently the recommended strategy 
by clinical practice guidelines for coronary angiography.1 
Nevertheless, there is no standard recommendation about 
the optimal coronary angiography strategy to perform 
these procedures. One-catheter strategy for radial coronary 
diagnostic procedures could help reduce radial spasm, 
complications related to contrast administration and 
exposure to ionizing radiation, since it avoids the exchange 
of angiography catheters during coronary procedures.4-8 
However, despite the potential benefits, one-catheter strategy 
for coronary angiography by transradial access is not routinely 
used in many centres. This fact may be due, among other 
factors, to the need for operators to perform the learning curve 
or to the scarcity of data about its impact on catheterization 
performance and economic costs.
Therefore, the objective of our study is to compare two 
strategies: a one-catheter strategy with TIG catheters6,9 vs. 
a traditional two-catheter strategy with Judkins catheters, in 
order to determine if one-catheter strategy allows to reduce 
the amount of iodinated contrast, radial spasm, exposure to 
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Figure 1 – Design of TIG I and Judkins catheters and cannulation of the coronary arteries. RCA: right coronary artery; LCA: left coronary artery.
Methods
Population and Study Design
This study compared, in an observational and retrospective 
way, the impact of one-catheter strategy with TIG I catheter 
(Radiofocus Optitorque 5F; Terumo Europe N.V., Leuven, 
Belgium) and two-catheter strategy with Judkins catheters 
(Infiniti® 5F Left and Right Coronary Judkins; Cordis 
Corporation, Cashel, Ireland) on the amount of iodinated 
contrast, appearance of radial spasm, duration of the 
procedures and exposure to ionizing radiations in patients 
referred for diagnostic coronary angiography in our institution 
(Figure 1). We collected data on the procedures performed in 
our institution. For repeated procedures in the same patient, 
data of each coronary angiography were included separately. 
The study was conducted according to the principles of the 
Helsinki Declaration and in compliance with current ethical 
and legal regulations. All patients signed a written informed 
consent form before coronary catheterization.
Inclusion and exclusion criteria are described below:
* Inclusion criteria:
– Indication for invasive coronary angiography.
– Right radial access.
– Patients >18 years.
* Exclusion criteria:
– Abnormal Allen’s test.
– Presence of brachial arteriovenous fistula in right 
upper extremity.
– Need to use 4Fr catheters.
– Previous coronary artery bypass grafting surgery.
– Performance of ventriculography, aortography or ad hoc 
coronary angioplasty.
– Iodinated contrast allergy previously known that cannot 
receive pre-medication.
– Women with possibility of being pregnant.
– Inclusion in other clinical trials or registries.
* Endpoints and Definitions:
Primary endpoint was total volume (mL) of iodinated 
contrast used during diagnostic coronary procedures.
Secondary endpoints were related to the development of 
radial spasm, duration of the procedure, exposure to ionizing 
radiation and economic costs.
Radial spasm was defined as the presence of at least two 
of the following criteria: a) catheter manipulation resistance; 
b) pain in the arm during catheterization; c) pain after catheter 
manipulation; d) pain after sheath removal or e) resistance 
during sheath removal.4
Duration of the coronary procedure was indirectly 
evaluated by fluoroscopy time (min).
Exposure to ionizing radiation was evaluated by dose-area 
product (DAP) and air kerma.
Economic costs, measured in € per procedure, were defined 
as the direct attributable costs to each strategy for coronary 
angiography, including the type and number of catheters, 
the drugs used in the cath lab, the fungible material and the 
amount of iodinated contrast used in each procedure.10,11 
Economic costs related to material used for coronary 
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Procedural issues
Only patients referred for diagnostic coronary angiography 
by right radial access were recruited, because TIG I catheters 
are not designed to perform coronary angiography by left 
radial access or femoral access.6,9 Patients were assigned to 
two-catheter or one-catheter strategy at the discretion of the 
interventional cardiologist.
Palpable right radial artery, as well non-pathological Allen’s 
test, were mandatory to perform right radial access. In order 
to minimize arterial spasm, sublingual diazepam (10 mg) was 
given 30 minutes before the administration of local anesthesia 
subcutaneously. Using the Seldinger technique, a 5 or 6 Fr 
hydrophilic radial Glidesheath was implanted (RADIFOCUS® 
INTRODUCER II; Terumo Europe N.V., Leuven, Belgium). 
Then, an intra-arterial bolus with 2 mg of verapamil and 
50 IU/Kg of unfractionated heparin was administered. 
The radial glide sheath was removed immediately after the 
diagnostic procedure, and hemostasis was obtained by 4-hour 
compression with conventional compressive dressings.12
Standard J-curve 0.035 guide wire (Radifocus M; Terumo 
Europe N.V., Leuven, Belgium) was used for the insertion and 
exchange of catheters. In order to obtain optimal quality images 
by coronary angiography, minimum of 5 views for the left 
coronary artery and minimum of 3 views for the right coronary 
artery were taken. The contrast volume used was 7 mL at 3 mL/sec 
for the left coronary artery and 4 mL at 2 mL/sec for the right 
coronary artery. However, the amount of contrast in each 
injection and the final number of views for correct assessment 
of the coronary tree was at the operator’s discretion.
Low-osmolar iodinated contrast media [Xenetix 350 (Iobitridol; 
Guerbert Group, Villepinte, France)] in combination with robotic 
contrast injector ACIST CVi® (ACIST Medical Systems, Eden 
Prairie, MN, USA) was used to make contrast administration 
uniform. The images were acquired as follows: low-quality 
fluoroscopy at 7.5 images/sec for coronary cannulation and 
cinefluoroscopy at 15 images/sec for coronary views.
Data related to baseline clinical characteristics, indication 
for coronary angiography and angiographic characteristics 
(number of coronary vessels with stenosis >50%), volume of 
iodinated contrast, radial spasm, access crossover, need for 
supplemental catheters, procedural duration, direct economic 
costs and information regarding exposure to ionizing radiations 
were collected. In the case of failure to engage the coronary 
artery ostium, crossover to alternative strategy was performed. 
All data generated were collected prospectively and entered 
into a specific computerized database.
Statistical analysis
SPSS Statistics 24.0 software package (SPSS Inc., Chicago, 
IL, USA) was used for data analysis. All p values  were evaluated 
in two tails, with p values < 0.05 considered statistically 
significant. Categorical variables were expressed as count 
(percentage) and were compared using the chi-square test. 
Continuous variables were explored for normal distribution 
using the Kolmogorov-Smirnov test. Normally distributed 
variables were expressed as mean (1 standard deviation) and 
non-normally distributed variables were expressed as median 
(interquartile range) and were compared using unpaired 
Student’s t-test or U Mann-Whitney tests as appropriate.
Results
A total of 1,953 diagnostic coronary procedures, in 
1,829 patients, was collected between January 2013 and 
June 2017. Two-hundred fifty-two procedures (12.9%) were 
performed by one-catheter strategy and 1,701 procedures 
(87.1%) by two-catheter strategy. The study flowchart is 
shown in Figure 2.
Baseline clinical characteristics
Baseline clinical characteristics are shown in Table 1. There were 
no differences between the two comparison groups
Procedural indications and angiographic characteristics
Data regarding angiographic indications and characteristics 
are shown in Table 2. No differences were detected between 
comparison groups in clinical presentation, diseased vessels 
and coronary artery disease extension.
Endpoints
Table 3 shows the comparative data regarding endpoints. 
The one-catheter strategy group received less amount of 
iodinated contrast than the two-catheter strategy group 
[77 (60–105) mL vs. 92 (64–120) mL; p < 0.001]. Also, the 
one-catheter strategy group presented less radial spasm 
(6.0% vs. 8.9%, p < 0.001) and shorter coronary procedures 
[Fluoroscopy time: 3.9 (2.2-8.0) min vs. 4.8 (2.9-8.3) min, 
p = 0.001] than the two-catheter strategy group.
No differences between one-catheter and two-catheter 
strategies were observed in access crossover (3.6% vs. 4.9%, 
p = 0.360) and need for supplemental catheters to complete 
coronary angiography (15.9% vs. 12.5%, p = 0.132). Also, there 
were no differences in exposure to ionizing radiations, evaluated 
as DAP [3488 (2556–5369) mGy.m2 vs. 3711 (2393-5762) 
mGy.m2; p = 0.831] and air kerma [582 (407–917) mGy vs. 
641 (424–974) mGy; p=0.165].
Regarding economic analysis, the one-catheter strategy 
reduced direct costs attributable to coronary procedures 
[149 (140–160) €/procedure vs. 171 (160–183) €/procedure; 
p < 0.001] in comparison with the conventional strategy.
Discussion
The main findings of our investigation were that 
one-catheter strategy, with TIG catheters, is associated with 
reduction in radial spasm, iodinated contrast consumption, 
duration of the coronary procedure and economic costs in 
coronary angiography.
Radial spasm is a relatively common complication during 
transradial coronary catheterization, and its incidence is 
variable, ranging from 5% to 30%.12-16 This complication 
reduces patient comfort and procedural success,1-13 and when 
it involves the need for crossover to transfemoral access it is 
related with an increase in vascular complications.17
Although the overall rate of radial spasm in our investigation 
(9.0%) was in the lower range of studies that have evaluated 
this item in coronary procedures, one-catheter strategy 
allowed reducing the incidence of radial spasm (one-catheter 
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Figure 2 – Study Flowchart.
Inclusion
– Invasive coronary angiography
– Right radial access
– > 18 years
Exclusion
– Abnormal Allen’s test
– Brachial arteriovenous fistula in right upper arm
– Nedd to use 4Fr catheters
– Previous coronary artery by-pass sugery
– Ventriculography, aortography or coronary angioplasty
– Iodin ated contrast allergy
– Women with possibility of being pregnant
– Inclusion in other clinical trials or registries
1,823 Patients
Total procedures (n = 1,953)
One-catheter strategy (n = 252) Two-catheter strategy (n = 1,701)
Primary Endpoint: Volume of iodinated contrast
Secondary Endpoint: Radial spasm, Fluoroscopytime,
Dose-area product, Air-kerma, Direct economic costs
Table 1 – Baseline clinical characteristics
Total procedures 
 (n = 1,953)
One-catheter strategy 
 (n = 252)
Two-catheter strategy 
 (n = 1,701) p-value
Age, (years), mean (SD) 67.3 (11.8) 67.5 (12.1) 67.2 (11.6) 0.695
Female gender, n (%) 611 (31.3%) 82 (32.5%) 529 (31.1%) 0.645
BMI, (kg/m2), mean (SD) 28.0 (5.3) 28.1 (4.8) 28.0 (5.4) 0.657
Hypertension, n (%) 1443 (73.9%) 187 (74.2%) 1256 (73.8%) 0.858
Dyslipidemia, n (%) 1096 (56.1%) 142 (56.3%) 954 (56.1%) 0.861
Diabetes mellitus, n (%) 701 (35.9%) 98 (38.9%) 603 (35.4%) 0.288
Smoking 0.539
Non-smoker, n (%) 304 (15.6%) 39 (15.5%) 265 (15.6%)
Previous smoker, n (%) 486 (24.9%) 56 (22.2%) 430 (25.3%)
Current smoker, n (%) 1160 (59.5%) 157 (62.3%) 1003 (59.1%)
Previous MI, n (%) 246 (12.6%) 27 (10.7%) 219 (12.9%) 0.426
Previous PCI, n (%) 318 (16.3%) 40 (15.9%) 278 (16.3%) 0.675
Family history of ischemic heart disease, n (%) 75 (3.8%) 11 (4.4%) 64 (3.8%) 0.669
Previous stroke, n (%) 65 (3.3%) 6 (2.4%) 59 (3.5%) 0.457
Chronic kidney disease, n (%) 223 (11.4%) 33 (13.1%) 190 (11.2%) 0.468
Creatinine (mg/dL), mean (SD) 1.15 (0.93) 1.07 (0.59) 0.647
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Table 2 – Procedural indications and angiographic characteristics
Total procedures 




(n = 1,701) p-value
Coronary angiography indication 0.684
Chronic ischemic heart disease, n (%) 610 (31.2%) 74 (29.4%) 536 (31.5%)
Acute coronary syndrome, n (%) 615 (31.5%) 77 (30.6%) 538 (31.6%)
Valvular heart disease, n (%) 372 (19.0%) 49 (19.4%) 323 (19.0%)
Myocardiopathy, n (%) 272 (17.1%) 43 (17.1%) 229 (13.5%)
Other, n (%) 84 (4.3%) 9 (3.6%) 75 (4.4%)
Left main coronary artery diseased, n (%) 155 (7.9%) 21 (8.3%) 134 (7.9%) 0.803
Number of diseased vessels 0.359
One vessel, n (%) 634 (32.5%) 83 (32.9%) 551 (32.4%)
Two vessels, n (%) 294 (15.1%) 32 (12.7%) 262 (15.4%)
Three vessels, n (%) 234 (12.0%) 25 (9.9%) 209 (12.3%)
Table 3 – Endpoints




Two-catheter strategy  
(n = 1,701) p-value
Volume of contrast, (mL), median (IQR) 90 (62-118) 77 (60-105) 92 (64-120) < 0.001
Radial spasm, n (%) 176 (9.0%) 13 (5.2%) 163 (9.3%) 0.022
Access crossover, n (%) 92 (4.7%) 9 (3.6%) 83 (4.9%) 0.360
Supplemental catheters, n (%) 252 (12.9%) 40 (15.9%) 212 (12.5%) 0.132
Direct costs, (€/procedure), median (IQR) 169 (158-182) 149 (140-160) 171 (160-183) < 0.001
DAP, (mGy.m2), median (IQR) 3685 (2408-5695) 3488 (2556-5369) 3711 (2393-5762) 0.831
Air kerma, (mGy), median (IQR) 630 (420-964) 582 (407-917) 641 (424-974) 0.165
Fluoroscopy time, (min), median (IQR) 4.7 (2.8-8.3) 3.9 (2.2-8.0) 4.8 (2.9-8.3) 0.001
IQR: interquartile range; SD: standard deviation; DAP: dose-area product.
These results are in line with three of the most recent 
randomized clinical trials, demonstrating a reduction in radial 
spasm by the one-catheter strategy.7,18,19
Many factors, such as age, female gender, multiple 
radial punctures and radial diameter, are related with radial 
spasm.4,14-16,20 Furthermore, exchange of catheters during 
transradial access has been linked to radial spasm induction, 
probably related to repeated stimulation of the radial artery.4 
As a result, radial spasm is not only associated with patient 
discomfort, procedural failure and morbidity and mortality, 
but also with high difficulty handling coronary catheters. 
This leads to more radiological tests to achieve cannulation 
of the coronary ostia and, therefore, to an increment in 
fluoroscopy time and total amount of iodinated contrast.
Iodinated radiological agents are related with several 
complications, highlighting contrast induced nephropathy 
(CIN). CIN, affecting 1% to 33% of patients referred for 
invasive coronary angiography, is one of the most common 
causes of acquired renal failure in cardiology patients.20-24 
The development of CIN after an invasive coronary procedure is 
associated with long hospital stay, marked increase in morbidity 
and mortality, as well as an increase in health costs.22,24
Classical studies have shown that iodinated contrast volume 
used in invasive coronary procedures is closely related to the 
onset of CIN.21,23,26 To date, most studies on CIN prevention 
have not focused on specific techniques for reducing contrast 
administration. Only a recent observational study has shown 
reduction in CIN secondary to a specific technique for 
decreasing contrast administration by using rotational coronary 
angiography.27 Therefore, savings with iodinated contrast 
by one-catheter strategy, as shown in our investigation and 
corroborated by multiple studies,7-10,18,27 could reduce CIN.
Studying the economic impact of medical interventions 
is crucial to assess the implementation of new diagnostic/
therapeutic techniques. A small observational study evaluated 
economic costs related to the use of TIG I catheter in a 
one-catheter strategy compared with Judkins catheters in a 
two-catheter strategy.28 Nevertheless, that study only evaluated 
costs related to the consumption of coronary catheters. To our 
best knowledge, our investigation is the first one evaluating all 
direct economic costs attributable to the one-catheter strategy 
for diagnostic coronary interventions. Our results show that 
it is related to a significant reduction in economic cost per 
procedure. This fact is mediated fundamentally by three 
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spasm, which reduces the use of more doses of spasmolytic 
medication and facilitates completion of diagnosis without using 
supplementary catheters and crossover to another arterial access 
with consequent expenditure on material; and c) reduced 
consumption of radiological contrast.
Although savings per unit are low (22 €/procedure), the 
long-term impact could be very important. Also, reduced use 
of iodinated contrast and the decrease in radial spasm could 
also reduce the indirect economic costs derived from CIN and 
crossover to transfemoral access.
Limitations of the study
Firstly, this study is an observational analysis with inherent 
biases. However, this is one of the largest studies to evaluate 
the impact of using a one-catheter strategy with TIG I 
catheters in invasive coronary procedures. Secondly, data 
refer to the population of our geographic area and, 
therefore, cannot be fully extrapolated to other geographic 
areas. Thirdly, the performance of ventriculography and the 
diagnostic coronary procedure protocol may differ between 
different cath labs. However, we consider that our coronary 
angiography protocol can be considered conservative in the 
administration of contrast by excluding ventriculography 
and limiting the number of angiographic views and the 
volume of iodinated contrast per angiographic view and, 
for these reasons, we consider that comparison groups were 
well-balanced and the final volume of contrast administered 
was not overestimated. Fourthly, the type of material used 
(sheaths and catheters), as well as the size of radial sheaths 
can influence the development of radial spasm. The absence 
of detailed data regarding the size of the radial sheaths is 
a limitation of our study. However, the use of hydrophilic 
sheaths and widely-used catheter trademarks allow our data 
to be extrapolated to other cath labs. Fifthly, the economic 
analysis contemplates only the direct costs of the diagnostic 
coronary procedure and they refer to the prices in our 
institution. Nevertheless, our study is the first one evaluating 
total direct economic costs related to one-catheter strategy 
for coronary angiography. Also, as the savings are conditioned 
by the lower use of catheters and radial spasm and by the 
reduction in contrast administration, we consider that results 
could be easily transferable to other centres.
Conclusions
The performance of diagnostic coronary angiography 
using the one-catheter strategy, with TIG catheters, was 
associated with better performance, in terms of radial 
spasm, administration of iodinated contrast and economic 
savings in diagnostic coronary procedures than conventional 
two-catheter strategy.
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Supplementary Material – Direct attributable costs related to coronary angiography procedures (Prices of material used for coronary angiography)
MATERIAL UNIT PRICE
Catheter TIGER I RH-5TIG110M Radiofocus Optitorque® 5F; Terumo Europe N.V., Leuven, Belgium 17.45 €
Catheter 534518T INFINITI® 5F Judkins Left; Cordis Corporation, Cashel, Ireland 17.95 €
Catheter 534523T INFINITI® 5F Judkins Right; Cordis Corporation, Cashel, Ireland 17.95 €
Xenetix 350 100mL/Bottle; Guerbert Group, Villepinte, France 35.09 €
Sheath RT-R50G10PQ RADIFOCUS® INTRODUCER II 5 Fr or 6 Fr; Terumo Europe N.V., Leuven, Belgium 10.71 €
Exchange Guidewire M001491031 Starter “J” Curved Fixed Core 0.035 x 260 cm; Boston Scientific, Marlborough, MA, USA 8.40 €
Sterile Pack CombiSet® REF 266315; Hartmann, Heidenheim, Germany 40.31 €
Injector control AngioTouch® Kit; ACIST Medical Systems, Inc, Eden Prairie, MN, USA 38.00 €
Mepivacaine 2%; BBraun, Melsungen, Germany 0.87 €
Heparin 1%; Hospira Prod. Farm. y Hosp S.L, Alcobendas, Spain 1.89 €
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